These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3415712)

  • 1. Microperfusion in coronary artery disease under treatment with the calcium antagonist gallopamil.
    Eichstädt H; Danne O; Gutmann M; Langer M; Felix R; Schmutzler H
    Arzneimittelforschung; 1988 May; 38(5):700-3. PubMed ID: 3415712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
    Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W
    Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial.
    Acanfora D; Vitale DF; Rengo C; Iannuzzi GL; Furgi G; Picone C; Rossi M; Trojano L; Rengo F
    Cardiology; 1997; 88(4):353-60. PubMed ID: 9197430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
    Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
    Mitrovic V; Oehm E; Minge C; Thürmann P; Schlepper M
    Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Profile of the hemodynamic effect of gallopamil at rest and during exercise by angiocardio-scintigraphic studies: preliminary data].
    Tartagni F; Marchetti G; Maiello L; Dondi M; Franchi R; Magnani B
    Cardiologia; 1987 Nov; 32(11):1249-53. PubMed ID: 3447697
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
    Hopf R; Drews H; Kaltenbach M
    Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
    Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
    Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
    Zebe H
    Fortschr Med; 1989 Feb; 107(5):134-8. PubMed ID: 2651251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
    Loskot F; Novotny P; Sucic P; Schneider G
    Z Kardiol; 1989; 78 Suppl 5():89-93. PubMed ID: 2698569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of retard gallopamil in patients with stress-induced ST-segment depression and silent myocardial ischemias].
    Barbato G; Klein H; Lichtlen PR
    Z Kardiol; 1989; 78 Suppl 5():98-102. PubMed ID: 2698571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study].
    Steinbeck C; Reuschel-Janetschek E; von Arnim T
    Z Kardiol; 1989; 78 Suppl 5():103-7. PubMed ID: 2698561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary gallopamil during percutaneous transluminal coronary angioplasty.
    Rauch B; Richardt G; Barth R; Zimmermann R; Tillmanns H; Schömig A; Kübler W; Neumann FJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S32-9. PubMed ID: 1284155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized comparison between gallopamil and diltiazem in angiography verified coronary heart disease].
    Zenker GD; Rödl S; Genger K
    Z Kardiol; 1989; 78 Suppl 5():94-7. PubMed ID: 2698570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil.
    Zehender M; Kosscheck U; Hohnloser S; Weiss C; Meinertz T; Just H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S57-63. PubMed ID: 1284158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of 75 mg retard gallopamil on stress-induced myocardial ischemia].
    Sinn R; Wolf R
    Z Kardiol; 1989; 78 Suppl 5():83-8. PubMed ID: 2698568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow-release gallopamil evaluated by exercise test and long-term electrocardiography.
    Steinbeck G; Reuschel-Janetschek E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S83-7. PubMed ID: 1284162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
    Rettig GF; Jakob M; Koch HP
    Z Kardiol; 1992 Oct; 81(10):525-30. PubMed ID: 1441691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris.
    Carboni GP; Saltarocchi ML; Risa AL; Scardovi AB; Zanchi E; Prati PL
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S64-70. PubMed ID: 1284159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of calcium antagonists and beta receptor blockers on coronary vessel diameter].
    Rafflenbeul W; Jost S; Berger C; Lichtlen P
    Z Kardiol; 1989; 78 Suppl 5():16-9. PubMed ID: 2631476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.